Literature DB >> 2511428

Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment.

H Ozawa1, M M Rasenick.   

Abstract

In an attempt to resolve a unified postreceptor mechanism of action for antidepressant therapy, rats were treated with amitriptyline, desipramine or iprindole. Chronic treatment with these antidepressant drugs increased guanylylimidodiphosphate-[Gpp(NH)p-], NaF-, or forskolin-activated adenylate cyclase in synaptic membranes prepared from cerebral cortexes of treated rats. Gpp(NH)p-dependent inhibition of adenylate cyclase was unaffected. Maximal binding of the photoaffinity GTP analog azidoanilido-GTP (AAGTP) to the adenylate cyclase stimulatory (Gs alpha) and inhibitory (Gi alpha) G proteins was unaffected by antidepressant treatment. The chemical elimination of Gs (low pH treatment) eliminated all differences between control and antidepressant-treated groups. Further, nonneural tissues from rats receiving chronic antidepressants showed no changes in adenylate cyclase activity or AAGTP binding. The results of these studies suggest that chronic antidepressant administration promoted increased coupling between Gs and catalytic unit of adenylate cyclase. Thus, the molecular locus of antidepressant action may reside at the stimulatory GTP-binding protein, Gs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511428

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

Review 1.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

2.  Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.

Authors:  Lanqiu Zhang; Mark M Rasenick
Journal:  J Pharmacol Exp Ther       Date:  2009-12-08       Impact factor: 4.030

3.  [On a new pharmacological action of antidepressants].

Authors:  M Bourin
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

4.  Alterations of tubulin function caused by chronic antidepressant treatment in rat brain.

Authors:  H Kamada; T Saito; S Hatta; S Toki; H Ozawa; M Watanabe; N Takahata
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

5.  Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling.

Authors:  John A Allen; Jiang Z Yu; Rahul H Dave; Anushree Bhatnagar; Bryan L Roth; Mark M Rasenick
Journal:  Mol Pharmacol       Date:  2009-08-20       Impact factor: 4.436

6.  Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients.

Authors:  H Ozawa; W Gsell; L Frölich; R Zöchling; F Pantucek; H Beckmann; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Lateral diffusion of Gαs in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains.

Authors:  Andrew H Czysz; Jeffrey M Schappi; Mark M Rasenick
Journal:  Neuropsychopharmacology       Date:  2014-09-24       Impact factor: 7.853

8.  Enhancement of cyclic AMP accumulation mediated by 5-HT after chronic amitriptyline treatment in NG 108-15 cells.

Authors:  M Shimizu; A Nishida; H Fukuda; H Saito; S Yamawaki
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

Review 9.  The Role of G-proteins and G-protein Regulating Proteins in Depressive Disorders.

Authors:  Nicolas B Senese; Mark M Rasenick; John R Traynor
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.